An in vitro model for toxin-mediated vascular leak syndrome: ricin toxin A chain increases the permeability of human endothelial cell monolayers.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Blood

• Publication date

  1997-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V90.6.2323.2323_2323_2334PMID 9310483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies.

  1996cited by this paper
• The adaptor protein Shc couples a class of integrins to the control of cell cycle progression.

  1996cited by this paper
• Fibronectin inhibits the cytotoxic effect of ricin A chain on endothelial cells.

  1996cited by this paper
• Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.

  1996cited by this paper
• Integrins inhibit LPS-induced DNA strand breakage in cultured lung endothelial cells.

  1996cited by this paper
• Alpha 2-macroglobulin receptor mediates binding and cytotoxicity of plant ribosome-inactivating proteins.

  1995cited by this paper
• Phase I Trial of an Anti‐CD19 Deglycosylated Ricin A Chain Immunotoxin in Non‐Hodgkin's Lymphoma: Effect of an Intensive Schedule of Administration

  1995cited by this paper
• Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study.

  1995cited by this paper
• Collagen is a survival factor against LPS-induced apoptosis in cultured sheep pulmonary artery endothelial cells.

  1995cited by this paper
• Immunotoxins as cancer chemotherapeutic agents

  1995cited by this paper
• Recombinant Toxins: New Therapeutic Agents for Cancer

  1995cited by this paper
• Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1

  1995cited by this paper
• Tracing the expression of CD7 and other antigens during T- and myeloid-cell differentiation in the human fetal liver and thymus.

  1995cited by this paper
• Regulation of endothelial cell gap formation and paracellular permeability.

  1995cited by this paper
• Disruption of epithelial cell-matrix interactions induces apoptosis

  1994cited by this paper
• Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity.

  1994cited by this paper
• Recent developments in immunotoxin therapy.

  1994cited by this paper
• Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells

  1994cited by this paper
• A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy.

  1993cited by this paper
• Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.

  1993cited by this paper
• Pseudomonas Exotoxin and Recombinant Immunotoxins Derived from It

  1993cited by this paper
• Addition of an endoplasmic reticulum retrieval sequence to ricin A chain significantly increases its cytotoxicity to mammalian cells.

  1993cited by this paper
• Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion.

  1993cited by this paper
• Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome.

  1993cited by this paper
• Immunotoxins: magic bullets or misguided missiles?

  1993cited by this paper
• Mutagenesis and kinetic analysis of the active site Glu177 of ricin A-chain.

  1993cited by this paper
• The extracellular matrix as a cell survival factor.

  1993cited by this paper
• Immunotoxins: magic bullets or misguided missiles?

  1993cited by this paper
• Distribution of the α2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues

  1992cited by this paper
• Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

  1992cited by this paper
• Ribosome–Inactivating Proteins from Plants: Present Status and Future Prospects

  1992cited by this paper
• High-level expression and simplified purification of recombinant ricin A chain.

  1992cited by this paper
• The toxicity of chemically deglycosylated ricin A-chain in mice.

  1992cited by this paper
• Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma.

  1991cited by this paper
• Adenosine diphosphate-ribosylation of G-actin by botulinum C2 toxin increases endothelial permeability in vitro.

  1991cited by this paper
• Phase I immunotoxin trial in patients with B-cell lymphoma.

  1991cited by this paper
• Role of albumin arginyl sites in albumin‐induced reduction of endothelial hydraulic conductivity

  1989cited by this paper
• Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.

  1989cited by this paper
• Role of glutamic acid 177 of the ricin toxin A chain in enzymatic inactivation of ribosomes

  1989cited by this paper
• Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells.

  1988cited by this paper
• Plasmid vectors for the analysis of regulatory sequences in yeast.

  1988cited by this paper
• Bacterial exotoxins and endothelial permeability for water and albumin in vitro.

  1988cited by this paper
• The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins.

  1987cited by this paper
• Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity.

  1987cited by this paper
• Mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes.

  1986cited by this paper
• Modification of the carbohydrate in ricin with metaperiodate and cyanoborohydride mixtures: effect on binding, uptake and toxicity to parenchymal and non-parenchymal cells of rat liver.

  1985cited by this paper
• Brain- and liver cell-derived factors are required for growth of human endothelial cells in serum-free culture.

  1984cited by this paper
• Role of Endothelial Cell Cytoskeleton in Control of Endothelial Permeability

  1982cited by this paper
• Mechanism of action of the toxic lectins abrin and ricin

  1974cited by this paper

• Toxicity and Efficacy Evaluation of Soluble Recombinant Ricin Vaccine

  2024cites this paper
• A novel EGFR-specific recombinant ricin-panitumumab (scFv) immunotoxin against breast and colorectal cancer cell lines; in silico and in vitro analyses.

  2023cites this paper
• Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies

  2022cites this paper
• Development of Recombinant Immunotoxins for Hairy Cell Leukemia

  2020cites this paper
• Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm.

  2020cites this paper
• Development of a highly sensitive in vitro endothelial cell toxicity assay for evaluating ricin toxin A chain-based vaccines or therapeutics.

  2019cites this paper
• Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy

  2018cites this paper
• Interactions Between Immunotoxins and the Plasma Membrane

  2018cites this paper
• Pathology of cattle experimentally intoxicated with ground Ricinus communis seeds

  2018cites this paper
• Treatments for Pulmonary Ricin Intoxication: Current Aspects and Future Prospects

  2017cites this paper
• The human vascular endothelial cell line HUV-EC-C harbors the integrated HHV-6B genome which remains stable in long term culture

  2017cites this paper
• Electrochemical Impedance Spectroscopy (EIS) as a Tool for Pathogen Detection

  2016cites this paper
• Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers

  2016cites this paper
• Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma

  2015cites this paper
• Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.

  2014cites this paper
• Ricin and Ricin-Containing Immunotoxins: Insights into Intracellular Transport and Mechanism of action in Vitro

  2013cites this paper
• Toxicity of ricin toxin A chain in rats

  2013cites this paper
• The induction of apoptosis by Shiga toxins and ricin.

  2012cites this paper
• Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity

  2012cites this paper
• Progress in Biological Threat Agent Vaccine Development

  2011influential citation
• Evaluation of a ricin vaccine candidate (RVEc) for human toxicity using an in vitro vascular leak assay.

  2011cites this paper
• A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation.

  2011cites this paper
• Tumorigenesis and Neoplastic Progression Ricinus communis Agglutinin I Leads to Rapid Down-Regulation of VEGFR-2 and Endothelial Cell Apoptosis in Tumor Blood Vessels

  2010cites this paper
• MOLECULAR MECHANISMS OF CYTOTOXICITY INDUCED BY RIBOSOME-INACTIVATING PROTEINS IN MAMMALIAN CELLS

  2010cites this paper
• Ricinus communis agglutinin I leads to rapid down-regulation of VEGFR-2 and endothelial cell apoptosis in tumor blood vessels.

  2010cites this paper
• Improved immunotoxins with novel functional elements.

  2009cites this paper
• Translocation of ricin across polarized human bronchial epithelial cells.

  2009cites this paper
• Ricin A-chain requires c-Jun N-terminal kinase to induce apoptosis in nontransformed epithelial cells.

  2009cites this paper
• Ricin and related toxins: review and perspective.

  2008cites this paper
• Proinflammatory responses of human airway cells to ricin involve stress-activated protein kinases and NF-kappaB.

  2007cites this paper
• Immunotoxins and toxin constructs in the treatment of leukemia and lymphoma.

  2004cites this paper
• Ricin Triggers Apoptotic Morphological Changes through Caspase-3 Cleavage of BAT3*

  2004cites this paper
• Antibody-Mediated Drug Delivery in Cancer Therapy

  2004cites this paper
• Induction of Apoptosis of Endothelial Cells by Viscum album: A Role for Anti-Tumoral Properties of Mistletoe Lectins

  2002cites this paper
• Designing immunotoxins for cancer therapy

  2002cites this paper
• Recombinant immunotoxins in targeted cancer cell therapy.

  2001cites this paper
• In vitro studies of ricin A-chain-induced vascular leak syndrome.

  2001cites this paper
• A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma.

  2000cites this paper
• The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage.

  2000cites this paper
• Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,).

  2000cites this paper
• Immunotoxins in cancer therapy.

  1999cites this paper
• Targeted toxins

  1999cites this paper
• Immunotoxins in cancer therapy.

  1999cites this paper
• Processing of preproricin in transgenic tobacco.

  1999cites this paper